LOW-VOLUME · HOSP-HEAVY

nabilone Side Effects

nabilone (also sold as Cesamet) is a LOW-VOLUME FAERS extract #461 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 39.8% mention hospitalization (782 reports).

Data updated 2026-05-15

1,963
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

nabilone: 39.8% mention hospitalization (782 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #461 of 524 by FAERS report count.

Thinner FAERS extract for nabilone (Cesamet) (1,963 reports #461 of 524 by FAERS report count). 39.8% mention hospitalization (782 reports). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

PAIN leads 473 of 1,963 reports

PAIN
473
MUSCULOSKELETAL STIFFNESS
285
INSOMNIA
265
RHEUMATOID ARTHRITIS
265
DRUG HYPERSENSITIVITY
254
GAIT DISTURBANCE
244
NAUSEA
230
FATIGUE
222
ARTHRALGIA
220
DIARRHOEA
193
WHITE BLOOD CELL COUNT ABNORMAL
193
HEADACHE
177
MALAISE
177
VOMITING
153
BACK PAIN
138
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
126
ASTHENIA
125
JOINT SWELLING
123

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 1,153 (67%)
Male 566 (33%)
Unknown 2

Age peak 45-64 (523 reports)

0-17 200 (15%)
18-44 284 (22%)
45-64 523 (40%)
65-74 261 (20%)
75+ 48 (4%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (102 reports, 5.2%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 44
CARDIAC ARREST 12
NAUSEA 9
ASTHENIA 8
ABDOMINAL PAIN 7
PAIN 7
DIARRHOEA 6
COMPLETED SUICIDE 5
DECREASED APPETITE 4
DIZZINESS 4
FATIGUE 4
GENERAL PHYSICAL HEALTH DETERIORATION 4
NEOPLASM PROGRESSION 4
VOMITING 4
COMA 3
DYSPNOEA 3
HYPOPHAGIA 3
LETHARGY 3

Reactions in Hospitalization Reports

Hospitalization is HEAVY (782, 39.8% of the book). Top reactions in those rows:

Reaction Reports
NAUSEA 99
INSPIRATORY CAPACITY DECREASED 97
VOMITING 76
PAIN 71
DIARRHOEA 67
PSYCHOTIC DISORDER 53
HEADACHE 52
MALAISE 52
ABDOMINAL PAIN 50
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50
THERAPEUTIC RESPONSE SHORTENED 50
FEBRILE NEUTROPENIA 48
FATIGUE 47
DYSPNOEA 46
ARTHRALGIA 45
DYSTONIA 45
ORTHOSTATIC HYPOTENSION 42
THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42
How to read nabilone FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 1,963 voluntary reports linked to nabilone (Cesamet), 2004-2025. Death is listed on 102 (5.2%). Hospitalization appears on 782 (39.8%). Top co-reported indication: Product Used For Unknown Indication.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with nabilone

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.